Welcome : Guest

Fluidigm Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Fluidigm Corporation, which is principally involved in providing Innovative Technologies and Life Science Tools. Illustrated with 91 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64393
Price: $3500
Company Type: Public
Pages: 96
Date: November 2016
Market Data Tables: 91

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Fluidigm Corporation’s Revenues by Category Worldwide (2014-2015) in Percentage for Product Revenue (Instruments, Consumables), and Service Revenue......5
Table 2: Fluidigm Corporation’s (Product and Services) Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, Europe, Asia Pacific, Japan, and Others......6
Biopharmaceuticals......7
Table 3: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......7
Clinical Laboratories......8
Table 4: Clinical Laboratory Market by Category in the US (2015) - Percentage Share Breakdown by Value for Hospital Inpatient, Hospital Outpatient, and Outside the Hospital......8
Table 5: Clinical Laboratory Market by Payer Type in the US (2015) - Percentage Share Breakdown by Value for Health Maintenance Organizations (HMOs), Medicare, Patient Self-Pay and Thirdparty Payer......9
Table 6: Clinical Labs Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Anatomic Pathology, Clinical Pathology, Cytology, Drugs of Abuse (DOA) and Esoteric/Molecular Pathology......10
Table 7: Clinical Testing Lab Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Hospital Labs, Independent Clinical Labs, Physician Office Labs and Others......11
Diagnostic Testing......12
Table 8: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......12
Table 9: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......13
Table 10: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......14
Table 11: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......15
Table 12: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......16
Table 13: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......17
Table 14: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......18
Table 15: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......19
Single Cell Omics......20
Table 16: Single Cell Omics Market by Application (2012-2017) in US$ Million for Subpopulation Characterization, Genomic Variation, Cell Differentiation/Reprograming, Method, Circulating Cells, and Others......20
Table 17: Single Cell Omics Market by Field of Study (2012-2017) in US$ Million for Basic Cell Biology, Immunology, Microbiology, Neurology, Oncology, Stem Cell Biology, and Others......21
Table 18: Single Cell Omics Market by Region/Country (2012-2017) in US$ Million for US, Europe, Asia-Pacific (Excl. Japan), Japan, and Rest of the World......22
Table 19: Single Cell Omics Market by Technology (2012-2017) in US$ Million for qPCR, NGS Sequencing, Microarrays, PCR, and Others......23
Table 20: Single Cell Omics Market Share by Customer Type - 2016E......24
Table 21: Single Cell Omics Market by Product (2012-2017) in US$ Million for Instruments, and Reagents......25
Genomic Technology......26
Table 22: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......26
Table 23: Genomic Technology for Applied Markets Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......27
Table 24: Genomic Technology for Biopharma Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......28
Table 25: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......29
Table 26: Genomic Technology for Academic/Government Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......30
Genomic Tools......31
Table 27: Genomics Tools Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for DNA Microarrays, Fluorescent in Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Sequencing, and Miscellaneous Reagents......31
Genomics 2.0......32
Table 28: Genomics 2.0 Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......32
Table 29: Genomics 2.0 Market for Oncology by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......33
Table 30: Genomics 2.0 for Reproductive Health Carrier Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......34
Table 31: Genomics 2.0 for Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......35
Table 32: Genomics 2.0 for Consumer Genomics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......36
Table 33: Genomics 2.0 for Forensics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......37
Table 34: Genomics 2.0 for Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......38
Table 35: Genomics 2.0 for In Vitro Fertilization (IVF) Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......39
Table 36: Genomics 2.0 for Livestock and Agriculture Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......40
Table 37: Genomics 2.0 for Microbiology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......41
Table 38: Genomics 2.0 for Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......42
Table 39: Genomics 2.0 for Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......43
Table 40: Genomics 2.0 for Reproductive Health Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......44
Table 41: Genomics 2.0 for Transplant, Human leukocyte antigen (HLA) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......45
Table 42: Genomics 2.0 Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......46
Genetic Testing......47
Table 43: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......47
Table 44: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......48
Table 45: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......49
DNA Carrier Testing......50
Table 46: DNA Carrier Testing Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......50
DNA & Gene Chips (Microarray)......51
Table 47: Global DNA & Gene Chip (Microarray) Market (2012-2017) in US$ Million......51
Table 48: Global Top 3 DNA Genotyping Microarray Vendors Market Share (2014) by Revenue for Illumina Inc., Affymetrix Inc., Sequenom Inc., and Others......52
Table 49: DNA Microarrays Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cytogenetics, Expression, Genotyping, and Others......53
Monoclonal Antibodies......54
Table 50: Monoclonal Antibodies Market by Drugs Worldwide (2015) - Percentage Share Breakdown by Value for Avastin, Crestor, Enbrel, Humira, Lantus, Remicade and Others......54
Cancer Drugs......55
Table 51: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......55
Table 52: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......56
Cancer Market......57
Table 53: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......57
Table 54: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......58
Table 55: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......59
Table 56: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......60
Table 57: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......61
Table 58: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......62
Table 59: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......63
Table 60: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......64
Cervical Cancer......65
Table 61: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......65
Table 62: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......66
Hematological Cancer......67
Table 63: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......67
Skin Cancer......68
Table 64: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......68
Cancer-Associated Mucositis......69
Table 65: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......69
Chronic Myelogenous Leukemia (CML)......70
Table 66: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......70
Multiple Myeloma......71
Table 67: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......71
Table 68: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......72
Biotechnology (Agricultural)......73
Table 69: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Others......73
Biopharmaceuticals......74
Table 70: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......74
Table 71: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......75
Clinical Laboratories......76
Table 72: Market Shares of Leading Clinical Laboratories in the US (2015) - Percentage Breakdown by Value Sales for Laboratory Corporation of America Holdings, Physician Office Partners, Inc., Quest Diagnostics Incorporated, and Others......76
Diagnostic Testing......77
Table 73: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......77
Genomics 2.0......78
Table 74: Market Shares of Leading Genomics 2.0 Service Providers in the US (2015) - Percentage Breakdown by Value for Illumina, Inc., Thermo Fisher Scientific Corporation, and Others......78
Cell Biology Products......79
Table 75: Market Shares of Leading Cell Biology Products Manufacturers in the US (2015) - Percentage Breakdown by Value for Life Technologies Corporation, and Others......79
Cancer Drugs......80
Table 76: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......80
Table 77: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......81
Table 78: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......82
Table 79: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......83
Table 80: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......84
Breast Cancer Drugs......85
Table 81: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......85
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......86
Table 82: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......86
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......87
Table 83: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......87
Table 84: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......88
Table 85: Fluidigm Corporation's Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Europe, Japan, United States and Other......89
Table 86: Fluidigm Corporation's Analytical Instruments Shipment by Segment (2015) - Percentage Share Breakdown by Volume for BioMark HD (High-Definition) System and EP1 System......90
Table 87: Fluidigm Corporation's Preparatory Instruments Shipment by Segment (2015) - Percentage Share Breakdown by Volume for Access Array System and C1 Single-Cell Auto Preparatory System......91
Table 88: Fluidigm Corporation's Instruments Shipment by Segment (2015) - Percentage Share Breakdown by Volume for Analytical and Preparatory......92
Table 89: Fluidigm Corporation's Sales by Product Segment (2015) - Percentage Share Breakdown by Value for Consumable and Instrument......93
Table 90: Fluidigm Corporation’s (Operations) Sales by Geographic Region Worldwide (2013-2014) in Percentage for United States, Europe, Asia-Pacific, Japan and Others......94
Table 91: Fluidigm Corporation’s Sales by Product Segment Worldwide (2013-2014) in Percentage for Product Revenue (Instruments and Consumables), License Revenue and Grant Revenue......95